Event

Melomanes project organises its Winter School on Advancing Cancer Treatment: Nanoparticles in Therapeutic Innovation, on Friday 13 December 2024, from 8:30am to 5:30pm, at Hôtel Mercure Paris Porte de Versailles Expo (36-38 rue du moulin, 92170 Vanves).

This event is in-person only. It is aimed at early-stage researchers interested in getting an overview of nanomedicine for cancer treatment.

Speakers

• Chloé GERVASONI, R&D and Production Laboratory Head, SON, Dijon, France
• Luca MONTICELLI, Researcher, Institut de Biologie et Chimie des Protéines, CNRS, Lyon, France
• Marie CARRIERE, Researcher, Molecular Systems and nanoMaterials for Energy and Health, CEA, Grenoble, France
• Claire WILHELM, Researcher, Institut Curie, Paris, France
• Alexane CAIGNARD, Business Development Manager Europe, Alvéole, Paris, France
• Twan LAMMERS, Professor of medicine, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
• Olivier TILLEMENT, Professor of chemistry, Institut Lumière Matière, Université Claude Bernard Lyon 1,Lyon, France
• Sacha LOEVE, Senior Lecturer in Philosphy, Institut de recherches philosophiques de Lyon, Université Jean Moulin Lyon 3, Lyon, France

Provisional Schedule

• 8:30 - 9:00 Welcome coffee
• 9:00 - 9:15 Introduction, Cécilia Ménard-Moyon, CNRS researcher and coordinator of the MSCA Doctoral Network Melomanes
• 9:15 - 10:00 Synthesis of multifunctional nanoparticles for therapeutic applications, Chloé GERVASONI
• 10:00 - 10:45 Computational methodologies to assess the interaction between biological membranes and carbon-based nanomaterials

  Normal
  0

  21

  false
  false
  false

  FR
  X-NONE
  X-NONE

  /* Style Definitions */
  table.MsoNormalTable
  {mso-style-name:"Tableau Normal";
  mso-tstyle-rowband-size:0;
  mso-tstyle-colband-size:0;
  mso-style-noshow:yes;
  mso-style-priority:99;
  mso-style-parent:"";
  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
  mso-para-margin-top:0cm;
  mso-para-margin-right:0cm;
  mso-para-margin-bottom:6.0pt;
  mso-para-margin-left:0cm;
  line-height:110%;
  mso-pagination:widow-orphan;
  font-size:10.0pt;
  font-family:"Calibri",sans-serif;
  mso-ascii-font-family:Calibri;
  mso-ascii-theme-font:minor-latin;
  mso-hansi-font-family:Calibri;
  mso-hansi-theme-font:minor-latin;
  mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:minor-bidi;
  mso-fareast-language:EN-US;}

  , Luca MONTICELLI

• 10:45 - 11:15 Coffee break
• 11:15 - 12:00 Nanoparticle toxicology: looking back on two decades of research, Marie CARRIERE
• 12:00 - 12:45 Nanoparticles-mediated cell therapies in cancer and regenerative medicine, Claire WILHELM
• 12:45 - 14:15 Lunch break
• 14:15 - 15:00 PRIMO: Create smarter cancer cell culture models, Alexane CAIGNARD
• 15:00 - 15:45 Changing paradigms or nano-pragmatism? Questioning the evolution of nanomedicine, Sacha LOEVE

  Normal
  0

  21

  false
  false
  false

  FR
  X-NONE
  X-NONE

  /* Style Definitions */
  table.MsoNormalTable
  {mso-style-name:"Tableau Normal";
  mso-tstyle-rowband-size:0;
  mso-tstyle-colband-size:0;
  mso-style-noshow:yes;
  mso-style-priority:99;
  mso-style-parent:"";
  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
  mso-para-margin-top:0cm;
  mso-para-margin-right:0cm;
  mso-para-margin-bottom:6.0pt;
  mso-para-margin-left:0cm;
  line-height:110%;
  mso-pagination:widow-orphan;
  font-size:10.0pt;
  font-family:"Calibri",sans-serif;
  mso-ascii-font-family:Calibri;
  mso-ascii-theme-font:minor-latin;
  mso-hansi-font-family:Calibri;
  mso-hansi-theme-font:minor-latin;
  mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:minor-bidi;
  mso-fareast-language:EN-US;}

  Normal
  0

  21

  false
  false
  false

  X-NONE
  AR-SA

  /* Style Definitions */
  table.MsoNormalTable
  {mso-style-name:"Tableau Normal";
  mso-tstyle-rowband-size:0;
  mso-tstyle-colband-size:0;
  mso-style-noshow:yes;
  mso-style-priority:99;
  mso-style-parent:"";
  mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
  mso-para-margin:0cm;
  mso-pagination:widow-orphan;
  font-size:10.0pt;
  font-family:"Times New Roman",serif;
  mso-ansi-language:#1000;
  mso-fareast-language:EN-US;}

• 15:45 - 16:05 Coffee break
• 16:05 - 16:50 Strategies to Promote Cancer Nanomedicine Performance and Clinical Translation, Twan LAMMERS
• 16:50 - 17:35 Ultrasmall Hybrid gadolinium-based Nanoparticle as clinical radiosensitizer, Olivier TILLEMENT

Normal
0

21

false
false
false

EN-US
X-NONE
X-NONE

Registration

Deadline

Registration is open until Thursday 5 December 2024.

Price

The registration to our workshop is free and includes coffee breaks.
Lunch is not included.

More Melomanes trainings

The meeting and training week of the Melomanes project, from Monday 9 December to Friday 13 December 2024, will include other symposia and lectures open to external participants, free and without registration. You can find more information on our website.

Note: If you encounter any difficulty, please contact Marion Roullet (Melomanes Project Manager) at m.roullet@ibmc-cnrs.unistra.fr

Normal
0

21

false
false
false

FR
X-NONE
X-NONE